<?xml version="1.0" encoding="UTF-8"?>
<p>Hydroxychloroquine (HCQâ€”
 <xref ref-type="fig" rid="jcm-09-02084-f007">Figure 7</xref>B, see brief description in 
 <xref rid="jcm-09-02084-t002" ref-type="table">Table 2</xref>) is a chloroquine analogue [
 <xref rid="B82-jcm-09-02084" ref-type="bibr">82</xref>], one of the antimalarials and other anti-inflammatory and antirheumatic agents associated with ocular toxicity and cardiomyopathy, is currently recommended in the treatment of immune diseases, such as systemic lupus erythematosus and rheumatoid arthritis [
 <xref rid="B83-jcm-09-02084" ref-type="bibr">83</xref>]. HCQ has been used for the last 30 years to treat intracellular bacterium 
 <italic>Coxiella burnetii</italic>, which produces the Q fever, being the only effective agent that kills intracellular pathogens. Another important therapeutic activity is against the intracellular bacterium 
 <italic>Tropheryma wippley</italic> [
 <xref rid="B84-jcm-09-02084" ref-type="bibr">84</xref>].
</p>
